Investigating the influence of perinatal fluoxetine exposure on murine gut microbial communities during pregnancy and lactation
Open Access
- 14 June 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Abstract
Selective Serotonin Reuptake Inhibitor (SSRI) therapy is common among perinatal populations for the treatment of mood disorders. Medications can affect diversity and composition of the gut microbiome, which plays a key role in modulating health. While previous studies have examined the effects of antidepressant exposure on the maternal gut microbiome, whether SSRI exposure affects the offspring gut microbiome is unknown. We investigated the effects of maternal fluoxetine exposure on the gut microbiome of maternal and offspring mice during pregnancy and lactation (embryonic day 10–lactation day 21; E10–L21). Stool samples collected on E17, L11, L15, and L21 were examined using 16S rRNA sequencing. Our results suggest that maternal fluoxetine exposure may result in decreased alpha diversity of the offspring gut microbiome in early life. Furthermore, we observed several genera-specific differences in the gut microbiome based on treatment, specifically of Turicibacter, Parasutterella, and Romboutsia. These findings support our understanding of gut health, as dysbiotic development of the gut microbiome has been associated with local and systemic health problems including gastrointestinal morbidities and interrupted growth patterns in infants. Future research should pursue study in human populations and those at high risk for gut microbial dysbiosis and intestinal injury.Keywords
Funding Information
- National Institutes of Health (5T32-DK007665, R01HD094759)
- University of Wisconsin-Madison Department of Bacteriology Roland and Nina Girolami Predoctoral Fellowship
This publication has 51 references indexed in Scilit:
- Exploring the human gut microbiota targets in relation to the use of contemporary antidepressantsJournal of Affective Disorders, 2023
- An overview of the currency and usefulness of behavioral tests used from past to present to assess anxiety, social behavior and depression in rats and miceBehavioural Processes, 2022
- Antidepressants in pregnancy2021
- Interactions between maternal fluoxetine exposure, the maternal gut microbiome and fetal neurodevelopment in miceBehavioural Brain Research, 2021
- The associations of the gut microbiome composition and short-chain fatty acid concentrations with body fat distribution in childrenClinical Nutrition, 2021
- The ever-changing roles of serotoninThe International Journal of Biochemistry & Cell Biology, 2020
- Contributors to Dysbiosis in Very-Low-Birth-Weight InfantsJournal of Obstetric, Gynecologic, & Neonatal Nursing, 2020
- Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005–2014)Archives of Women's Mental Health, 2020
- The international prevalence of antidepressant use before, during, and after pregnancy: A systematic review and meta-analysis of timing, type of prescriptions and geographical variabilityJournal of Affective Disorders, 2020
- Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectivenessJournal of Affective Disorders, 2017